WAKE-UP试验:急性缺血性卒中严重不良事件及其对功能结局的影响
WAKE-UP试验的事后分析纳入503例发病时间不明的急性缺血性卒中患者,199例严重不良事件(SAE)发生于110例(22%),其中20例(10%)死亡。发生SAE者90天良好功能结局(mRS 0-1)的调整OR为0.36(95%CI 0.21-0.61,P<0.001),高龄和男性是SAE预测因素。
要点
- 约22%的急性缺血性卒中患者发生SAE,其中10%死亡。
- 发生SAE与90天良好功能结局几率降低独立相关(调整OR 0.36)。
- 高龄和男性是SAE发生的预测因素。
核心结论
- SAE见于约五分之一患者,在高龄和男性中更常见,并与更差的功能结局相关。
研究设计与样本
- WAKE-UP随机对照试验的事后分析,纳入503例发病时间不明、接受MRI引导静脉阿替普酶溶栓的急性缺血性卒中患者。
主要发现
- 110例(22%)患者共报告199例SAE,发生SAE者中20例(10%)结局为死亡。
- 发生至少1例SAE者90天达到良好结局(mRS 0-1)的调整OR为0.36(95%CI 0.21-0.61,P<0.001)。
- 高龄(P=0.04)和男性(P=0.01)是SAE发生的预测因素。
临床怎么用
- 临床实践中应警惕卒中后严重并发症,尤其对高龄和男性患者。
- 未来卒中试验可参考这些结果评估SAE风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: During the first days and weeks after an acute ischemic stroke, patients are prone to complications that can influence further treatment, recovery, and functional outcome. In clinical trials, severe complications are recorded as serious adverse events (SAE). We analyzed the effect of SAE on functional outcome and predictors of SAE in the randomized controlled WAKE-UP trial (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke). METHODS: We performed a post hoc analysis of WAKE-UP, a multicenter, randomized, placebo-controlled clinical trial of magnetic resonance imaging-guided intravenous thrombolysis with alteplase in patients with acute ischemic stroke and unknown time of onset. Functional outcome was assessed by the modified Rankin Scale 90 days after the stroke. SAE were reported to a central safety desk and recorded and categorized by organ system using Medical Dictionary for Regulatory Activities terminology. We used logistic regression analysis to determine the effect of SAE on functional outcome and linear multiple regression analysis to identify baseline predictors of SAE. RESULTS: Among 503 patients randomized, 199 SAE were reported for n=110 (22%) patients. Of those patients who did suffer a SAE, 20 (10%) had a fatal outcome. Patients suffering from at least one SAE had a lower odds of reaching a favorable outcome (modified Rankin Scale score of 0-1) at 90 days (adjusted odds ratio, 0.36 [95% CI, 0.21-0.61], P<0.001). Higher age (P=0.04) and male sex (P=0.01) were predictors for the occurrence of SAE. CONCLUSIONS: SAEs were observed in about one in 5 patients, were more frequent in elderly and male patients and were associated with worse functional outcome. These results may help to assess the risk of SAE in future stroke trials and create awareness for severe complications after stroke in clinical practice. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01525290. URL: https://eudract.ema.europa.eu; Unique identifier: 2011-005906-32.
引用
- Lettow I, Jensen M, Schlemm E, et al. Serious Adverse Events and Their Impact on Functional Outcome in Acute Ischemic Stroke in the WAKE-UP Trial. Stroke. 2021. PMID: 34433305. doi:10.1161/STROKEAHA.120.033425
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。